Medical

Diabetes doubles risk of certain cancers – new report

Health Industry Hub | May 27, 2020 |
[Total: 1    Average: 5/5]

Medical News: Australians living with type 2 diabetes have a 60% higher chance of developing dementia than those without diabetes, and are twice as likely to develop some types of cancer, according to a new report analysing the full impact of the condition.

Released yesterday by the Baker Heart and Diabetes Institute, The Dark Shadow of Type 2 Diabetes report shines light on high-risk areas that are becoming increasingly recognised as complications of diabetes.

The latest national snapshot of type 2 diabetes shows a better approach is needed to address the wider health risks for the 1.5 million Australians currently living with type 2 diabetes, especially the growing number of those under 40 who may live with the disease for decades.

The report’s lead author and Head of Clinical Diabetes and Population Health at the Baker Institute, Professor Jonathan Shaw said diabetes increased the risk of numerous other diseases that most people may not understand were linked.

Register FREE & join 22,000+ industry professionals in reading the latest industry news & engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

“This is what we are calling ‘the dark shadow of type 2 diabetes’, as it can cast a much wider shadow than many realise,” Professor Shaw said.

A recent meta-analysis involving data from two million people showed those living with type 2 diabetes had a 60% greater risk of developing dementia compared to people without diabetes, with women more at risk than men.

Professor Shaw said people with type 2 diabetes were also more likely to develop many types of cancer.

“They are two to three times more likely to develop pancreatic cancer – one of the most deadly cancers, are twice as likely to develop liver or endometrial cancer, have a 50% higher chance of getting bowel cancer and a 20% greater risk of breast cancer,” he said.

You may also like PRIME Awards 2020 call for entries – the only awards program dedicated to recognising excellence within Australian healthcare communications, is now open for entries.

“Increased cancer risk is of particular concern for the growing number of people under 40 living with type 2 diabetes. This group saw a significant increase in deaths from cancer between 2000 and 2011.”

On average, a 45 year old person with diabetes can expect to live six years less than a person free of diabetes, and Professor Shaw said many of these earlier deaths were due to heart disease.

“Heart disease is still the biggest killer of people with type 2 diabetes, and our report shows that heart failure is a leading cause,” he said.

“People with type 2 diabetes are up to eight times more likely to suffer from heart failure, compared to those without diabetes.”

But Professor Shaw said the report also highlighted recent advances around the world showing that some of the newer diabetes medications had the potential to significantly reduce the number of people with diabetes who develop heart and kidney disease.

“In addition to controlling blood sugar levels, it is essential Australians living with type 2 diabetes are supported to keep blood pressure and cholesterol at healthy levels.”

Researchers at the Baker Institute are currently working to understand more about diabetes and how to prevent some of its devastating effects through large-scale research projects, including the PREDICT study.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Medical Technology

MedTech News - Private health insurer looking to invest in Australian private hospitals

Private health insurer looking to invest in Australian private hospitals

Health Industry Hub | July 15, 2020 |

MedTech News: In a recent opinion piece Dr Bill Coote, former AMA Secretary General and former Director of the Medicare […]

More


News & Trends - Pharmaceuticals

Pharma News - Merck Australia supports the first Australian-developed COVID-19 vaccine - Sypharma and Vaxine

Merck Australia supports the first Australian-developed COVID-19 vaccine

Health Industry Hub | July 15, 2020 |

Pharma News: Sypharma, an Australian biopharmaceutical formulation company, announced manufacturing of COVAX-19 and Advax adjuvant for Covid-19 in partnership with […]

More


News & Trends - Pharmaceuticals

Pharma News - Precision prescribing to combat Australia’s expected surge in mental illness

Precision prescribing to combat Australia’s expected surge in mental illness

Health Industry Hub | July 15, 2020 |

Pharma News: COVID-19 social isolation, familial and community disconnection, shock, job loss and health fears create the perfect storm for […]

More


Medical

Medical Pharma Biotech MedTech - $47M accelerator program for MedTech, Biotech and Pharma sectors in diabetes and cardiovascular disease

$47M accelerator program for MedTech, Biotech and Pharma sectors in diabetes and cardiovascular disease

Health Industry Hub | July 15, 2020 |

Medical News: The operation of the Australian Government’s $47 million Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular […]

More